Wedge Capital Management L L P Harrow Health, Inc. Transaction History

Wedge Capital Management L L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$6.68 - $11.07 $1.06 Million - $1.76 Million	-158,827 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$6.26 - $11.03 $994,257 - $1.75 Million	158,827 New	158,827 $1.07 Million
Q1 2020 Apr 13, 2020	SELL	$3.5 - $7.31 $511,052 - $1.07 Million	-146,015 Closed	0 $0
Q4 2019 Jan 15, 2020	SELL	$4.6 - $7.88 $31,335 - $53,678	-6,812 Reduced 4.46%	146,015 $1.14 Million
Q2 2019 Aug 01, 2019	BUY	$4.2 - $8.7 $641,873 - $1.33 Million	152,827 New	152,827 $1.33 Million

185

21.1M

679K

1.27M

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $660M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.